Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 March 2025 | Story Andre Damons | Photo Andre Damons
Prof Aliza le Roux
Prof Aliza le Roux, Assistant Dean of the Faculty of Natural and Agricultural Sciences and Professor in the Department of Zoology and Entomology, at the Southern African Mountain Conference (SAMC2025).

Animals in mountainous areas around the world, in particular endangered, vulnerable, and near threatened mammals, are at risk of becoming roadkill as road networks expand further into these previously inaccessible terrains.

These mammals, which fall into the category of conservation risk according to the International Union for Conservation of Nature (IUCN) definitions, include African wild dogs (endangered), lions and leopards (both vulnerable), elephants (endangered), and honey badgers (NT – near threatened). Among the road-killed birds found in these areas are the hooded vulture (critically endangered) and the endangered steppe eagle.

This is according to Prof Aliza le Roux, Assistant Dean of the Faculty of Natural and Agricultural Sciences and Professor in the Department of Zoology and Entomology, who presented research during a session at the Southern African Mountain Conference (SAMC2025). Prof Le Roux, a behavioural ecologist studying how animals respond to risks and opportunities in the environment, did an oral presentation titled Patterns of wildlife-vehicle collision in montane environments during a session on Mountain biodiversity: animals.

The conference, under the patronage of UNESCO and organised by the University of the Free State (UFS) Afromontane Research Unit (ARU) – in partnership with the African Mountain Research Foundation (AMRF) and the Global Mountain Safeguard Research Programme (GLOMOS) – brought together researchers, policy makers, and practitioners from across Southern Africa and beyond. It delved into critical issues around mountain ecosystems, communities, governance, and transboundary cooperation.

For the research, Prof Le Roux, Dr Katlego Mashiane, Lecturer in the UFS Department of Geography, and Dr Clara Grilo from the BIOPOLIS project in Portugal, looked for published data/papers from 1971 to 2024, finding that most of the published literature on roadkill in Africa came from the 21st Century.

 

Heightens risks to wildlife

According to her, they found that amphibians were killed at the highest rate in the mountainous regions, while mammals were killed most frequently in the low-lying regions. Mammalian species classified as near threatened or more vulnerable to extinction on the IUCN Red List were most frequently found in the high-elevation mountains (7,7% of species killed in these areas), but also in low-lying areas (3,8% of mammalian roadkill). About 3% of the birds killed at moderate elevations were also of conservation concern.

“Increased vehicular traffic and better-paved roads in montane environments heighten the risks to wildlife inhabiting these regions, including the potential for more wildlife-vehicle collisions, leading to higher mortality rates. In terms of sheer numbers, many more small species (less than 1 kg in adult weight) are killed than larger species. This is probably because we either don’t see them or don’t care if we hit them. But we do care if our cars collide with something large like an eland – it does damage to us as well as them.”

“Unpredictable weather patterns and sudden topographical changes all contribute to these roads potentially being more hazardous for both drivers and any surrounding wildlife: the ruggedness of these terrains and tortuosity of roads can make it harder for drivers and wild animals to detect one another on mountain roads, increasing the likelihood of collisions,” writes Prof Le Roux and her colleagues.

The researchers estimated the roadkill rates for each observed species and then analysed the correlation with topographic aspects of the study sites. They used the 90m digital elevation model downloaded from the geospatial cloud-computing platform Google Earth Engine and classified ‘high’ elevation mountains as regions lying above 2 000 metres above sea level (masl), ‘moderate’ elevation mountains as lying between 1 500 and 2 000 masl, and ‘low’ regions as areas below 1 500 masl.

 

Limited data

Prof Le Roux and Dr Mashiane also extracted slope and the topographic ruggedness index. Roadkill rates were estimated for 15 different amphibian species, 98 reptilian, 261 avian, and 273 mammalian species, comprising 5 549 individual road kills.

“These findings indicate that roads in mountainous African regions pose a high risk to our indigenous wildlife. The accidents in mountainous areas are something to be aware of, as we are moving further into mountains where there is often vulnerable and unique biodiversity. When we do kill vertebrates through a collision, it is often a species that we would not find in low-lying areas.”

Unfortunately, Prof Le Roux says, they cannot say what the continental patterns are because so little data is available about biodiversity and roadkill patterns in the central and western parts of the continent. The data they found came from only 10 countries, and almost none of the studies took the form of systematic, longitudinal monitoring. The data sets were all ‘snapshots’ of roadkill in specific areas.

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept